Friday, March 29, 2024

Rabiot pens new PSG deal

SoccerNews in Serie A 31 Oct 2014

73 Views

Adrien Rabiot has ended speculation regarding his future by signing a new long-term deal with Paris Saint-Germain.

The highly rated teenager, whose previous contract was set to expire at the end of the season, had been heavily linked with a move to Roma in January after the Serie A club’s sporting director Walter Sabatini made their interest public last month.

However, Rabiot put pen to paper on a four-year extension to his deal with PSG on Friday, keeping him at the Parc des Princes until 2019.

And the French midfielder, a product of the Ligue 1 champions’ youth system, is delighted to be staying put.

“I am very happy to remain a player of Paris Saint-Germain, the club that made me the player I am today,” the 19-year-old told PSG’s official website.

“I would like to thank the president [Nasser Al Khelaifi], who kept discussions open in recent months.

“It was here at Paris Saint-Germain that I grew up and enjoyed my first experiences as a player. The club’s project is ambitious, and I’m very proud to be a part of it for the coming years.

“Now I want to concentrate on my football, on my game and give my best for Paris Saint-Germain on the pitch and for the supporters.”

Rabiot, who made 25 Ligue 1 appearances last term, has been restricted to reserve-team football so far this season, due to a combination of injury and the uncertainty surrounding his future.

However, the France Under-21 international will hope to force his way back into Laurent Blanc’s first-team plans now he has committed to PSG.

ABOUT THE AUTHOR

SoccerNews

Soccernews.com is news blog for soccer with comprehensive coverage of all the major leagues in Europe, as well as MLS in the United States. In addition we offer breaking news for transfers and transfer rumors, ticket sales, betting tips and offers, match previews, and in-depth editorials.

You can follow us on Facebook: Facebook.com/soccernews.com or Twitter: @soccernewsfeed.

SHARE OR COMMENT ON THIS ARTICLE

WE RECOMMEND

Leave a Reply

Your email address will not be published. Required fields are marked *

This field is required *

Join the conversation!

or Register

More More
Top